Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy

被引：0
|
作者：
Dandan Linghu
Hui Xu
Zhiqiao Liang
Tingting Gao
Zhaojun Lin
Xiaoxin Li
Lvzhen Huang
Mingwei Zhao
机构：
[1] Peking University People’s Hospital,Department of Ophthalmology
[2] Eye Diseases and Optometry Institute,College of Optometry
[3] Beijing Key Laboratory of Diagnosis and Therapy of Retina and Choroid Diseases,undefined
[4] Peking University Health Science Center,undefined
来源：
International Ophthalmology | 2020年 / 40卷
关键词：
Single nucleotide polymorphisms; Complement factor H; Verteporfin photodynamic therapy; Central serous chorioretinopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：951 / 956
页数：5
相关论文
共 50 条
  • [21] Photodynamic therapy for steroid-associated central serous chorioretinopathy
    Lee, Tae-Gon
    Kim, Judy E.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (04) : 518 - 523
  • [22] Photodynamic Therapy as Treatment of Chronic Idiopathic Central Serous Chorioretinopathy
    Tarantola, Ryan M.
    Law, Janice C.
    Recchia, Franco M.
    Sternberg, Paul, Jr.
    Agarwal, Anita
    LASERS IN SURGERY AND MEDICINE, 2008, 40 (10) : 671 - 675
  • [23] Microperimetric Changes After Photodynamic Therapy for Central Serous Chorioretinopathy
    Senturk, Fevzi
    Karacorlu, Murat
    Ozdemir, Hakan
    Karacorlu, Serra Arf
    Uysal, Omer
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2011, 151 (02) : 303 - 309
  • [24] Low Fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
    Husain, D.
    Shah, N.
    Abedi, G.
    Blaha, G. R.
    Ness, S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [25] Severe phenotypes of chronic central serous chorioretinopathy: clinical characteristics and response to photodynamic therapy
    Mohabati, D.
    van Dijk, E. H. C.
    van Rijssen, T. J.
    de Jong, E. K.
    Breukink, M. B.
    Martinez-Ciriano, J. P.
    Dijkman, G.
    Hoyng, C. B.
    Fauser, S.
    Yzer, S.
    Boon, C. J. F.
    ACTA OPHTHALMOLOGICA, 2017, 95 : 21 - 21
  • [26] Clinical characteristics and response to photodynamic therapy in severe phenotypes of chronic central serous chorioretinopathy
    Mohabati, Danial
    Van Dijk, Elon H. C.
    Talib, Mays
    de Jong, Eiko
    Fauser, Sascha
    Hoyng, Carel C. B.
    Yzer, Suzanne
    Boon, Camiel J. F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [27] Prognostic factors related to photodynamic therapy for central serous chorioretinopathy
    Moon, Jun Woong
    Yu, Hyeong Gon
    Kim, Tae Wan
    Kim, Hyung Chan
    Chung, Hum
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (10) : 1315 - 1323
  • [28] Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy
    Chan, Wai-Man
    Lai, Timothy Y. Y.
    Lai, Ricky Y. K.
    Tang, Emily W. H.
    Liu, David T. L.
    Lam, Dennis S. C.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2008, 28 (01): : 85 - 93
  • [29] Half-Time Photodynamic Therapy for Central Serous Chorioretinopathy
    Tsai, Meng-Ju
    Hsieh, Yi-Ting
    OPTOMETRY AND VISION SCIENCE, 2014, 91 (09) : 1140 - 1145
  • [30] Prognostic factors related to photodynamic therapy for central serous chorioretinopathy
    Jun Woong Moon
    Hyeong Gon Yu
    Tae Wan Kim
    Hyung Chan Kim
    Hum Chung
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247 : 1315 - 1323
12345